Quick Answer
RIGEL PHARMACEUTICALS INC reported Cash And Cash Equivalents At Carrying Value of $40.58 million for the year ending 2025.
- RIGEL PHARMACEUTICALS INC showed a decrease of -28.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from RIGEL PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), RIGEL PHARMACEUTICALS INC's Cash And Cash Equivalents At Carrying Value has declined by 11.8%.
- Historical annual values: Fiscal year 2025: $40.58 million | Fiscal year 2024: $56.75 million | Fiscal year 2023: $32.79 million | Fiscal year 2022: $24.46 million | Fiscal year 2021: $18.89 million | Fiscal year 2020: $30.37 million | Fiscal year 2019: $22.52 million | Fiscal year 2018: $76.32 million | Fiscal year 2017: $38.29 million | Fiscal year 2016: $17.63 million | Fiscal year 2015: $43.46 million | Fiscal year 2014: $15.20 million | Fiscal year 2013: $20.85 million | Fiscal year 2012: $33.48 million | Fiscal year 2011: $18.63 million | Fiscal year 2010: $8.88 million | Fiscal year 2009: $14.72 million | Fiscal year 2008: $46.01 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: